€29.30
0.68% yesterday
Helsinki, Nov 15, 04:37 pm CET
ISIN
FI0009010912
Symbol
REG1V
Sector

Revenio Group Stock price

€29.24
-3.54 10.80% 1M
+0.62 2.17% 6M
+2.08 7.66% YTD
+5.48 23.06% 1Y
-27.96 48.88% 3Y
+2.49 9.31% 5Y
+24.31 492.71% 10Y
Helsinki, Closing price Fri, Nov 15 2024
-0.26 0.88%
ISIN
FI0009010912
Symbol
REG1V
Sector

Key metrics

Market capitalization €777.67m
Enterprise Value €778.97m
P/E (TTM) P/E ratio 40.71
EV/FCF (TTM) EV/FCF 40.13
EV/Sales (TTM) EV/Sales 7.64
P/S ratio (TTM) P/S ratio 7.62
P/B ratio (TTM) P/B ratio 7.68
Dividend yield 1.29%
Last dividend (FY23) €0.38
Revenue growth (TTM) Revenue growth 6.47%
Revenue (TTM) Revenue €102.00m
EBIT (operating result TTM) EBIT €25.40m
Free Cash Flow (TTM) Free Cash Flow €19.41m
Cash position €13.50m
EPS (TTM) EPS €0.72
P/E forward 42.55
P/S forward 7.57
EV/Sales forward 7.58
Show more

Is Revenio Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Revenio Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Revenio Group forecast:

4x Buy
57%
3x Hold
43%

Analyst Opinions

7 Analysts have issued a Revenio Group forecast:

Buy
57%
Hold
43%

Financial data from Revenio Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
102 102
6% 6%
100%
- Direct Costs 57 57
12% 12%
56%
45 45
0% 0%
44%
- Selling and Administrative Expenses 3.60 3.60
43% 43%
4%
- Research and Development Expense 11 11
30% 30%
11%
31 31
1% 1%
30%
- Depreciation and Amortization 5.10 5.10
34% 34%
5%
EBIT (Operating Income) EBIT 25 25
4% 4%
25%
Net Profit 19 19
9% 9%
19%

In millions EUR.

Don't miss a Thing! We will send you all news about Revenio Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The firm's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices, and perimeters. The company was founded in 2001 and is headquartered in Vantaa, Finland.

Head office Finland
CEO Jouni Toijala
Employees 216
Founded 2001
Website www.reveniogroup.fi

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today